Finzati - Logo
TBRG logo

TruBridge, Inc.

TBRG • Medical - Healthcare Information Services
$26.24
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$382.19M
Growth
1.9%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 5.1%Positive free cash flow · 2.46Consistent free cash flow · 4/5Healthy liquidity · 1.81Expensive earnings multiple · 73.44
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 8, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$26.24
Change0.00%
Shares Out14.56M
Market Cap$382.19M
Enterprise Value$512.21M
52W Range13.88 - 26.51
Beta1.29
P/E86.84
P/S1.10
P/B2.14
P/FCF10.76
EV/Sales1.48

Investment DNA

How strong this company looks for long-term investors

60
out of 100
Business Quality
Margins, moat, returns
37/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
47/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score▼
Positive revenue growth · 5.1%Positive free cash flow · 2.46Consistent free cash flow · 4/5Healthy liquidity · 1.81Expensive earnings multiple · 73.44Weak profitability

Analyst view

Analyst sentiment and price target

TBRG
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
66/100
Neutral
Bullish
7
Hold
15
Bearish
0
Price Target
2026-07-02
Low
$23.00
Mean
$25.44
Median
$26.25
High
$26.25

Company Overview

IPO: 5/21/2002
Industry: Medical - Healthcare Information Services
P/B i: 2.14
Debt / Equity i: 0.94
Operating Margin: 6.01%
Net Margin: 1.26%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.94
Current Ratio: 1.81
Quick Ratio: 1.79
Status: Good

Insider Transactions

Recent executive and insider activity

MacIntyre Vita
Transaction: 04/08/2026
BUY
Change
+909
Price
Not reported
Filing
04/09/2026
Type
BUY
Wilson Merideth
Transaction: 04/08/2026
BUY
Change
+5,206
Price
Not reported
Filing
04/09/2026
Type
BUY
Harse David
Transaction: 04/08/2026
BUY
Change
+5,079
Price
Not reported
Filing
04/09/2026
Type
BUY